Popular on s4story
- Ohio SFWA Author New Sci-fi Action-Adventure Cover Reveal and ARC availability
- New Novel Honors and Documents Obliteration of American Chestnut Forests
- [New Book] "Secret Wisconsin: A Guide to the Weird, Wonderful, and Obscure" Available Now!
- Mend the World in 14 Days: Climate Book "2 Weeks 2 Utopia" Now in Paperback
- Former DEI Officer Poised to Resume Work in Civil Rights Space After Addressing False Allegations
- Frank McElvain Reveals The Family Lessons Learned from War in New Book SFC: A Poor Man's Battle
- New Children's Book Explores What It Means To Feel Afraid—Teaching Perseverance Through Adventure
- New from Down & Out Books: KILLIN' TIME IN SAN DIEGO, Bouchercon Anthology 2023
- When Cris Met Kringle, A Mrs. Claus Origin Story, Is Sure to be A New Holiday Classic
- The #1 Mistake Drivers Make When They Get in a Traffic Accident
Similar on s4story
- Live Good Inc. Celebrates Diversity and Unity: A Beacon of Progress in the Spirit of Crissy Field, Angel Island and the Buffalo Soldiers
- The 2023 CGI Integrated Care Conference Explores Opportunities in Healthcare Improvement Discovered as a Result of the COVID-19 Pandemic
- Autonomous eVTOLs $25 Billion Market by 2030
- Material Capital Partners Completes Exit of The Preserve at Sweetwater, Expands BFR Pipeline in the Southeast
- North Carolina Entrepreneur Awarded 2023 Small Business Advocate of the Year By NSBA
- Customer Agility Framework™ soft launch
- Sparkling Logic Launching Generative AI-Powered Tool for Decision Management
- 5 Steps to an Exceptional Presentation
- SHO-TEK Expands Nationwide PMO Consulting Services; Launches Free PMO Assessment Tools
- Pizza Hut Joins Colony Ridge Communities, Amplifying the Neighborhood's Vibrant Offerings!
Caris Life Sciences and Flatiron Health Partner to Vastly Increase Access to Most Comprehensive Molecular Testing Available
S For Story/10556422
Partnership broadens precision medicine access at the point of care with seamless ordering and receipt of Caris molecular profiling results directly in patient records via the OncoEMR® platform
IRVING, Texas, Sept. 23, 2022 /PRNewswire/ -- Caris Life Sciences®(Caris), the leading molecular science and technology company actively developing and delivering innovative solutions to revolutionize healthcare, today announced a partnership with Flatiron Health, a healthtech company dedicated to helping cancer centers thrive and deliver better care for patients, to integrate Caris' market leading molecular testing portfolio with OncoEMR®, a leading cloud-based electronic medical record (EMR) tool.
"The integration with OncoEMR is another milestone achievement along our goal of making personalized precision healthcare accessible to as many physicians and patients as possible," said David Spetzler, M.S., Ph.D., MBA, President and Chief Scientific Officer of Caris. "Delivering critical molecular results directly at the point of care in community oncology settings is paramount to every patient's ability to fight, and hopefully beat cancer. Integrating within the OncoEMR platform, which reaches almost 40 percent of all U.S. community oncologists, significantly aids in delivering on our commitment."
The Molecular Profiling Integration between OncoEMR and Caris enables data-driven clinical decision making for over 2,000 clinicians within the Flatiron network, made up of more than 800 unique cancer care locations across the country. Through the Molecular Profiling Integration, users can easily submit Caris orders with fewer clicks and less data entry, track real-time status updates, and receive the results directly within OncoEMR. This streamlines clinical workflows for physicians and offers access to Caris molecular reports in the same environment in which they develop care plans. In addition to presenting time-saving benefits within the clinician ordering process, the cloud-based integration is easily enabled–with no associated cost or development work–to any practice in the Flatiron network that wants it.
More on S For Story
"Insight into tumor biology enables precision medicine, and this Molecular Profiling Integration with Caris allows oncologists and their teams to efficiently order molecular profiling tests, track order status and view results, all without leaving OncoEMR. Simplifying the workflow can promote appropriate and equitable testing, eliminate redundant tests, minimize practice disruption, and surface therapeutic opportunities with the goal of better patient outcomes," said James Hamrick, Vice President Clinical Oncology at Flatiron Health. "We are thrilled for this partnership with Caris to further enhance delivering a better care experience for physicians and their patients, as we reimagine the infrastructure of cancer care."
Caris' entire suite of molecular profile services, including comprehensive whole exome and whole transcriptome sequencing, is now available for ordering within the OncoEMR network. Caris is the first and only partner with whole exome and whole transcriptome sequencing capabilities to integrate with Flatiron's OncoEMR and plans to continue collaborating with EMR/EHR systems across both academic and community oncology spaces on new ways to integrate genomic results into patient care and education.
About Caris Life Sciences
Caris Life Sciences® (Caris) is the leading molecular science and technology company actively developing and delivering innovative solutions to revolutionize healthcare and improve patient outcomes. Through comprehensive molecular profiling (Whole Exome and Whole Transcriptome Sequencing) and the application of advanced artificial intelligence (AI) and machine learning algorithms, Caris has created the large-scale clinico-genomic database and cognitive computing needed to analyze and unravel the molecular complexity of disease. This information provides an unmatched resource and the ideal path forward to conduct the basic, fundamental research to accelerate discovery for detection, diagnosis, monitoring, therapy selection and drug development to improve the human condition.
With a primary focus on cancer, Caris' suite of market-leading molecular profiling offerings assesses DNA, RNA and proteins to reveal a molecular blueprint that helps patients, physicians and researchers better detect, diagnose and treat patients. Caris' latest advancement is a blood-based, circulating nucleic acids sequencing (cNAS) assay that combines comprehensive molecular analysis (Whole Exome and Whole Transcriptome Sequencing from blood) and serial monitoring – making it the most powerful liquid biopsy assay ever developed.
More on S For Story
Headquartered in Irving, Texas, Caris has offices in Phoenix, New York, Denver, Tokyo, Japan and Basel, Switzerland. Caris provides services throughout the U.S., Europe, Asia and other international markets. To learn more, please visit CarisLifeSciences.com or follow us on Twitter (@CarisLS).
About Flatiron Health
Flatiron Health is a healthtech company dedicated to helping cancer centers thrive and deliver better care for patients today and tomorrow. Through clinical and data science, we translate patient experiences into real-world evidence to improve treatment, inform policy, and advance research. Cancer is smart. Together, we can be smarter. Flatiron Health is an independent affiliate of the Roche Group. Flatiron.com @FlatironHealth
Caris Life Sciences Media Contact:
Lisa Burgner
[email protected]
214.294.5606
Flatiron Media Contact:
Nina Toor
[email protected]
SOURCE Caris Life Sciences
IRVING, Texas, Sept. 23, 2022 /PRNewswire/ -- Caris Life Sciences®(Caris), the leading molecular science and technology company actively developing and delivering innovative solutions to revolutionize healthcare, today announced a partnership with Flatiron Health, a healthtech company dedicated to helping cancer centers thrive and deliver better care for patients, to integrate Caris' market leading molecular testing portfolio with OncoEMR®, a leading cloud-based electronic medical record (EMR) tool.
"The integration with OncoEMR is another milestone achievement along our goal of making personalized precision healthcare accessible to as many physicians and patients as possible," said David Spetzler, M.S., Ph.D., MBA, President and Chief Scientific Officer of Caris. "Delivering critical molecular results directly at the point of care in community oncology settings is paramount to every patient's ability to fight, and hopefully beat cancer. Integrating within the OncoEMR platform, which reaches almost 40 percent of all U.S. community oncologists, significantly aids in delivering on our commitment."
The Molecular Profiling Integration between OncoEMR and Caris enables data-driven clinical decision making for over 2,000 clinicians within the Flatiron network, made up of more than 800 unique cancer care locations across the country. Through the Molecular Profiling Integration, users can easily submit Caris orders with fewer clicks and less data entry, track real-time status updates, and receive the results directly within OncoEMR. This streamlines clinical workflows for physicians and offers access to Caris molecular reports in the same environment in which they develop care plans. In addition to presenting time-saving benefits within the clinician ordering process, the cloud-based integration is easily enabled–with no associated cost or development work–to any practice in the Flatiron network that wants it.
More on S For Story
- Sheila Stubbs Taylor of Detroit music royalty is "Chasing" on new single
- Sidow Sobrino Announces 12th Album, "Seminal"
- Heartland Soccer Association and VidSport Launch Groundbreaking Live Streaming Service at Garmin Olathe Soccer Complex
- Waterside Productions Announces John Lockton's Second Novel The Prisoner of Secrets
- Texas State Student Miles Skonberg Takes Center Stage as the Winner of TKP Design Competition
"Insight into tumor biology enables precision medicine, and this Molecular Profiling Integration with Caris allows oncologists and their teams to efficiently order molecular profiling tests, track order status and view results, all without leaving OncoEMR. Simplifying the workflow can promote appropriate and equitable testing, eliminate redundant tests, minimize practice disruption, and surface therapeutic opportunities with the goal of better patient outcomes," said James Hamrick, Vice President Clinical Oncology at Flatiron Health. "We are thrilled for this partnership with Caris to further enhance delivering a better care experience for physicians and their patients, as we reimagine the infrastructure of cancer care."
Caris' entire suite of molecular profile services, including comprehensive whole exome and whole transcriptome sequencing, is now available for ordering within the OncoEMR network. Caris is the first and only partner with whole exome and whole transcriptome sequencing capabilities to integrate with Flatiron's OncoEMR and plans to continue collaborating with EMR/EHR systems across both academic and community oncology spaces on new ways to integrate genomic results into patient care and education.
About Caris Life Sciences
Caris Life Sciences® (Caris) is the leading molecular science and technology company actively developing and delivering innovative solutions to revolutionize healthcare and improve patient outcomes. Through comprehensive molecular profiling (Whole Exome and Whole Transcriptome Sequencing) and the application of advanced artificial intelligence (AI) and machine learning algorithms, Caris has created the large-scale clinico-genomic database and cognitive computing needed to analyze and unravel the molecular complexity of disease. This information provides an unmatched resource and the ideal path forward to conduct the basic, fundamental research to accelerate discovery for detection, diagnosis, monitoring, therapy selection and drug development to improve the human condition.
With a primary focus on cancer, Caris' suite of market-leading molecular profiling offerings assesses DNA, RNA and proteins to reveal a molecular blueprint that helps patients, physicians and researchers better detect, diagnose and treat patients. Caris' latest advancement is a blood-based, circulating nucleic acids sequencing (cNAS) assay that combines comprehensive molecular analysis (Whole Exome and Whole Transcriptome Sequencing from blood) and serial monitoring – making it the most powerful liquid biopsy assay ever developed.
More on S For Story
- Maryland Sedation Dentistry and Surgical Center Opens in Frederick Maryland
- LokiBots is one of the 35 early-stage Generative AI startups selected for AWS ML Elevate program 2023 cohort
- Mil-Spec Safety & Security Launches New Website
- Trinity Prairie Real Estate Lists Mesmerizing 16.78-Acre Estate in Colleyville, Texas
- "Secret Iowa: A Guide to the Weird, Wonderful, and Obscure" Available Now!
Headquartered in Irving, Texas, Caris has offices in Phoenix, New York, Denver, Tokyo, Japan and Basel, Switzerland. Caris provides services throughout the U.S., Europe, Asia and other international markets. To learn more, please visit CarisLifeSciences.com or follow us on Twitter (@CarisLS).
About Flatiron Health
Flatiron Health is a healthtech company dedicated to helping cancer centers thrive and deliver better care for patients today and tomorrow. Through clinical and data science, we translate patient experiences into real-world evidence to improve treatment, inform policy, and advance research. Cancer is smart. Together, we can be smarter. Flatiron Health is an independent affiliate of the Roche Group. Flatiron.com @FlatironHealth
Caris Life Sciences Media Contact:
Lisa Burgner
[email protected]
214.294.5606
Flatiron Media Contact:
Nina Toor
[email protected]
SOURCE Caris Life Sciences
0 Comments
Latest on S For Story
- New York Times Praised Author Gunter Swoboda Inks Deal with Bonfire Cinema for his latest, the Supernatural Brian Poole Mysteries
- Tobu Railway Launches Its Latest Model "Spacia X" Express Train with 40% Reduced CO2 Emissions Compared with the Previous Spacia Fleet
- New Book By Organizational Psychologist Explores And Explains Hidden Costs Of Perfectionism
- Axiros Launches a New Release of their USP Agent - AXACT 2023.4
- North Carolina Entrepreneur Awarded 2023 Small Business Advocate of the Year By NSBA
- Instant Gourmet Coffee With The Authentic Taste & Refreshing Smell Of Cafe De Olla, Infused With The Wonderful Health Benefits Of Superfoods
- A Riveting Expose of Why the GOP uses Race to Dominate American Politics
- The 39th Annual Cuesta College Central Coast Writers' Conference - October 14, 2023
- Berlin Packaging Fires Female Executive Following Complaints of Discrimination
- Follow the Evolution of Conservation with the Former Director of the U.S. Fish and Wildlife Service
- Falcomm selected for 2023 TechCrunch Startup Battlefield 200
- Patton Acquires Tone Commander
- Thomas Reed Delivers a Profound, Globe-Trotting Journey of Grief and Family in POCKETFUL OF POSEYS
- Customer Agility Framework™ soft launch
- Winning: A Story Of Grief And Renewal - Available Now
- New Kickstarter Campaign - 7 Exclusive Novels from Ray Keating
- Trump is Still Here and So is the book Two Years of Trump on the Psychiatrist's Couch
- Moolwan releases 10 new Home Decor Items to help customers decorate their homes into opulent masterpieces
- The Falcon, the Wolf, and the Hummingbird by Martha Engber, now available from Histria Books
- Introducing Vertical Hold Press: A Fresh Voice in Young Adult and Science Fiction Genres